Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2026-04-13 @ 6:55 PM
Study NCT ID:
NCT01876368
Status:
COMPLETED
Last Update Posted:
2015-12-07
First Post:
2013-06-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of LCZ696 Compared to Olmesartan in Essential Hypertensive Patients Not Responsive to Olmesartan
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-09
Start Date Type:
None
Primary Completion Date:
2014-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-08
Completion Date Type:
ACTUAL
First Submit Date:
2013-06-09
First Submit QC Date:
None
Study First Post Date:
2013-06-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-07-29
Results First Submit QC Date:
None
Results First Post Date:
2015-12-07
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-11-03
Last Update Post Date:
2015-12-07
Last Update Post Date Type:
ESTIMATED